Eva Wulsten

Title: Eva Wulsten: Innovator in Pharmaceutical Formulations

Introduction

Eva Wulsten is a notable inventor based in Willich, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications for pain management. With a total of 3 patents to her name, Wulsten's work focuses on improving the stability and effectiveness of pharmaceutical compositions.

Latest Patents

Wulsten's latest patents include an "Aqueous pharmaceutical formulation of tapentadol for oral administration." This invention features an aqueous composition containing tapentadol or a physiologically acceptable salt, designed for oral use. The formulation boasts excellent storage stability without the need for high amounts of preservatives. Another significant patent is for a "Stable formulation for parenteral administration of tapentadol." This invention involves an aqueous composition for parenteral use, with a specific concentration of tapentadol and a buffered pH range, making it particularly useful for treating acute pain, especially in pediatric patients.

Career Highlights

Throughout her career, Eva Wulsten has worked with prominent companies in the pharmaceutical industry, including Grünenthal GmbH. Her expertise in pharmaceutical formulations has positioned her as a key player in developing effective pain management solutions.

Collaborations

Wulsten has collaborated with notable professionals in her field, including Ulrich Reinhold and Marc Schiller. These partnerships have contributed to her innovative work and the advancement of pharmaceutical formulations.

Conclusion

Eva Wulsten's contributions to pharmaceutical innovations demonstrate her commitment to improving pain management through effective formulations. Her patents reflect her expertise and dedication to enhancing patient care.